Capozzi Vito Andrea, Monfardini Luciano, Maglietta Giuseppe, Barresi Giuseppe, De Finis Alessandra, Rosati Andrea, Vargiu Virginia, Cosentino Francesco, Sozzi Giulio, Chiantera Vito, Bogani Giorgio, Carnelli Marco, Scambia Giovanni, Fanfani Francesco, Ghi Tullio, Berretta Roberto
Department of Medicine and Surgery, University Hospital of Parma, Parma, 43125, Italy.
Clinical and Epidemiological Research Unit, University Hospital of Parma, 43125, Parma, Italy.
Eur J Surg Oncol. 2024 Mar;50(3):107985. doi: 10.1016/j.ejso.2024.107985. Epub 2024 Jan 28.
Endometrial cancer recurrence occurs in about 18 % of patients. This study aims to analyze the pattern recurrence of endometrial cancer and the relationship between the initial site of primary disease and the relapse site in patients undergoing surgical treatment.
We retrospectively reviewed all surgically treated patients with endometrial cancer selecting those with recurrence. We defined primary site disease as uterus, lymph nodes, or peritoneum according to pathology analysis of the surgical specimen. The site of recurrence was defined as vaginal cuff, lymph nodes, peritoneum, and parenchymatous organs. Our primary endpoint was to correlate the site of initial disease with the site of recurrence.
The study enrolled 1416 patients. The overall recurrence rate was 17,5 % with 248 relapses included in the study. An increase of 9.9, 5.7, and 5.7 times in the odds of relapse on the lymph node, peritoneum, and abdominal parenchymatous sites respectively was observed in case of nodal initial disease (p < 0.001). A not significant difference in odds was observed in terms of vaginal cuff relapse (OR 0.9) between lymph node ad uterine primary disease (p = 0.78). An increasing OR of 8.7 times for nodal recurrences, 46.6 times for peritoneum, and 23.3 times for parenchymatous abdominal recurrences were found in the case of primary peritoneal disease (p < 0.001).
Endometrial cancer tends to recur at the initial site of the disease. Intraoperative inspection of the adjacent sites of primary disease and targeted instrumental examination of the initial sites of disease during follow-up are strongly recommended.
约18%的子宫内膜癌患者会出现复发。本研究旨在分析子宫内膜癌的复发模式以及接受手术治疗患者的原发疾病初始部位与复发部位之间的关系。
我们回顾性分析了所有接受手术治疗的子宫内膜癌患者,并挑选出复发患者。根据手术标本的病理分析,将原发部位疾病定义为子宫、淋巴结或腹膜。复发部位定义为阴道残端、淋巴结、腹膜和实质器官。我们的主要终点是将初始疾病部位与复发部位进行关联。
该研究纳入了1416例患者。总体复发率为17.5%,研究中共包括248例复发患者。在淋巴结为初始疾病的情况下,观察到淋巴结、腹膜和腹部实质部位复发几率分别增加了9.9倍、5.7倍和5.7倍(p < 0.001)。在阴道残端复发方面,淋巴结和子宫原发疾病之间的几率差异不显著(OR为0.9,p = 0.78)。在原发腹膜疾病的情况下,发现淋巴结复发的OR增加了8.7倍,腹膜复发增加了46.6倍,腹部实质复发增加了23.3倍(p < 0.001)。
子宫内膜癌倾向于在疾病的初始部位复发。强烈建议在术中检查原发疾病的相邻部位,并在随访期间对疾病的初始部位进行针对性的仪器检查。